FDA advisers cast doubt on seasonal updates

THE US Food and Drug Administrationthe panel of independent advisors of raised doubts on the need to “periodic” update Covid vaccines, noting that it is unclear if the virus is seasonal like the flu.

Thursday Advisors voted unanimously that new jabs for fall should be monovalent – ​​meaning they are designed against a variant of Covid – and target one of omicron XBB Strains. These are now the dominant variants at national scale.

But the original polling question included language indicating whether the panel recommends a “periodic update” of the Covid plans.

Dr. Peter Marks, head of the FDA’s vaccines division, asked the panel chair to remove wording from the question after several advisers raised concerns.

“As it’s worded, it seems to say, do we agree that there will be a need for regular updating? And I don’t think that’s clear,” Dr Arthur said. Reingold, professor of epidemiology at the University of California, Berkeley.

The panel’s concerns indicate that there is still uncertainty about what the Covid pandemic will look like in the coming years, even as cases and deaths decline nationwide.

Concerns are also the latest pushback against the FDA proposed change to annual Covid injections earlier this year – a simplified approach to vaccination that would involve annual injection updates. It’s similar to how the United States rolls out new flu vaccines every fall and winter, which is the season when cases spike.

But several advisers have warned against calling seasonal Covid the flu.

“I don’t know yet if it’s a seasonal virus,” said Henry Bernstein, a pediatrician at Cohen Children’s Medical Center.

Dr Mark Sawyer, professor of clinical pediatrics at the University of California, San Diego, added that describing Covid as “seasonal” could ultimately confuse the public about “when and where they should get vaccinated, and how often”.

“I’m going to join the choir here. I think the use of the word season is just as problematic,” he said. Dr. Sawyer. “It links the campaign to the flu vaccine. I understand that it can be convenient and more efficient to administer the vaccines together, but it’s only been a few years and we really don’t know what the Covid season is.”

Unlike the flu, the spread of Covid has often been erratic. The virus is constantly mutating into new variants and has yet to settle into a predictable seasonal pattern.

In response to advisers, the FDA’s Marks pointed out that Covid injections will likely require another update “at some point.”

“It will not be the final formulation of this vaccine forever,” he said.

The move to an annually updated Covid vaccine is backed by former White House health officials Dr Ashish Jha and Dr Anthony Fauci, who believe the country can benefit from adopting an approach similar to the flu vaccine.

Each year, researchers evaluate circulating flu strains and estimate which will be most prevalent during the fall and winter before updating bites.

“People are going to get the flu shot every year, if they see it as a routine part of care. I don’t – every time I get the flu shot, I don’t think, is it my 28th flu shot or my 29th flu – I just think it’s my annual flu shot,” Jha said in a Wednesday interview on PBS News Hour.

“For most people, if they consider it their annual COVID vaccine, they get it when they get their flu shot, I think that will make a big difference,” he continued.

A recent poll suggests the public is open to the idea.

According to an April investigation by the health policy organization KFF. This includes 32% who would be “very likely” to do so.

It’s unclear how many Americans will roll up their sleeves for updated snaps this fall and winter.

Adoption of the newer bivalent boosters – which target the original Covid strain and omicron BA.4 and BA.5 – has been slow.

Just about 17% of the US population — approximately 56 million people — received Pfizer And Modern recalls since their approval in September, according to the Centers for Disease Control and Prevention.

First manufacturer of Covid shots Pfizer told CNBC last month that an annual Covid calendar could encourage more people to get vaccinated each year.

The change could help people see Covid injections as another “very natural part” of protecting their health, said Dr Mikael Dolsten, chief scientific officer of Pfizer.

Pfizer is already preparing to move to an annual schedule by developing “next-generation” versions of its vaccine, which aim to broaden and extend the protection people get from the virus to a full year.